The People Who Drive BioFabUSA

See ARMI|BioFabUSA’s dedicated Leadership Team, Board of Directors, Stakeholder Council and Leadership Advisory Council.

Leadership

DEAN KAMEN

Executive Director & Chairman of the Board

Maureen Toohey

Deputy Executive Director & Secretary of the Board

Jennifer Macdonald

M.D. Chief Operating Officer, ARMI

Jim Scott
Chief Administrative Officer
Thomas Bollenbach

Ph.D., Chief Technology Officer

Richard McFarland

Ph.D., M.D., Chief Regulatory Officer

Stefany Shaheen

Chief Strategy Officer

Julie Lenzer

Chief Innovation Officer

Ned Gordon

Chief Operating Officer, BioFabUSA

Board of Directors

Like-minded people—who are from different spheres but have changed the world in their own ways—make up ARMI’s board of directors.

DEAN KAMEN

ARMI Executive Director, DEKA CEO, serial inventor and FIRST founder

Dr. Martine Rothblatt

United Therapeutics CEO and Sirius Satellite Radio founder

John Abele

Boston Scientific founder and medical device pioneer

Dr. Jim Weinstein

Senior Vice President for Microsoft Healthcare, and former CEO of Dartmouth-Hitchcock

Blake Moret

Rockwell Automation CEO and veterans and workforce-development champion

DR. ELISABETH REYNOLDS

MIT Professor of the Practice, expert in manufacturing & systems of innovation

Dr. Winston Oluwole Soboyejo

President of SUNY Polytechnic Institute, engineering thought leader

Stakeholder Council

The Stakeholder Council consists of the ARMI board of directors and key personnel from the U.S. Department of Defense.

BG Edward H. Bailey, Commanding General U.S. Army Medical Research and Development Command
Dr. Kate Sixt, Office of the Secretary of Defense
Kathleen Berst, Defense Health Agency
Dr. Lloyd Rose, U.S. Army Medical Materiel Development Activity
Tracy Frost, Office of the Secretary of Defense

Leadership Advisory Council

The Leadership Advisory Council (LAC) provides industry expertise and strategic guidance to the stakeholder council. BioFabUSA’s membership elects members of the council. Five of the members of the LAC also hold membership in the Technical Advisory Subcommittee (TASC).

Anna Argo, Cytotheryx, Inc  

David Brafman, Ph,D., Arizona State University (ASU)  

Carter Cliff, StemCardia  

Michael Golway, P.E., Advanced Solutions Life Sciences (ASLS) 

Paul Goodwin, Cytiva, TASC  

Brian Hawkins, Ph.D., Pluristyx, TASC  

Katherine Hixon, Ph.D., Dartmouth  

Stu Jacobson, Ph.D., DEKA   

Esther Latres, Ph.D., BreakthroughT1D  

Cato Laurencin, M.D., Ph.D., University of Connecticut (UConn)    

Dave Mann, Ph.D., Vascugen   

Marian G. McCord, Ph.D., University of New Hampshire (UNH)   

George Pins, Ph.D., Worcester Polytechnic Institute (WPI), TASC    

Steven Rees, Ph.D., Defined Bioscience, Inc, TASC   

Eric Schuur, Ph.D., HepaTx  

Ramille Shah, Ph.D., Dimension, Inx  

James Sherley, M.D., Ph.D., Asymmetrex® LLC  

Matt Weaver, Rockwell Automation, TASC  

Sandy Williams, Ph.D., Access Biomedical  

Winston K. Wong, Eppendorf 

 

ARMI

Initiatives

Learn more about work underway to build the biofabrication ecosystem and accelerate the science of regenerative medicine.